Bernasconi, Enos

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Piccoli, L., Park, Y.-J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., et al. (2020) · Cell

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 1,395

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2019) · The Lancet

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,023

Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.

Wandeler, G., Gsponer, T., Bregenzer, A., Günthard, H. F., Clerc, O., Calmy, A., Stöckle, M., Bernasconi, E., Furrer, H., & Rauch, A. (2012) · Clinical Infectious Diseases

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 241

Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.

Rauch, A., Martin, M., Weber, R., Hirschel, B., Tarr, P. E., Bucher, H. C., Vernazza, P., Bernasconi, E., Zinkernagel, A. S., Evison, J., et al. (2005) · Clinical Infectious Diseases

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 210

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

Glass, T., Ungsedhapand, C., Wolbers, M., Weber, R., Vernazza, P., Rickenbach, M., Furrer, H., Bernasconi, E., Cavassini, M., Hirschel, B., et al. (2006) · HIV Medicine

HIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 156

Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study

Conen, A., Wang, Q., Glass, T. R., Fux, C. A., Thurnheer, M. C., Orasch, C., Calmy, A., Bernasconi, E., Vernazza, P., Weber, R., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 56

Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey

Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 37

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Otte, F., Zhang, Y., Spagnuolo, J., Thielen, A., Däumer, M., Wiethe, C., Stoeckle, M., Kusejko, K., Klein, F., Metzner, K. J., et al. (2023) · Cell Reports Methods

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 4